The Department of Health (DOH) is tasked to issue updated guidelines on the use of rapid test kits in the Philippines for intensified efforts against the coronavirus disease (Covid-19).
These guidelines will adhere to the requirements and recommendations of the Health Technology Assessment Council (HTAC) under the Universal Health Care Act.
Rapid test kits, which analyze blood samples to detect antibodies, provide results in minutes or hours.
This is a faster alternative to the 24 to 48-hour turnaround time for swab samples processed by the Research Institute for Tropical Medicine (RITM) using machine-based methods.
As of April 3, the country has approved 30 PCR-based and antibody rapid test kits for commercial use, including locally developed PCR-based test kits from UP Manila's National Institutes of Health.
The rapid test kits measure antibodies, not the viral load itself, distinguishing them from PCR-based tests which assess swabs for the presence of the virus.
Topics in this story
Explore more stories about these topics.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.



